Aspen Pharmacare 

€6.9
0
+€0.2+2.99% Today

Statistics

Day High
6.95
Day Low
6.7
52W High
7.6
52W Low
4.46
Volume
0
Avg. Volume
39
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3MarExpected
Q4 2024
0.32
0.66
0.99
1.32
Expected EPS
N/A
Actual EPS
0.323820169148

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LDZA.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap153.13B
Pfizer is a global pharmaceutical company that competes with Aspen in various therapeutic areas, including anti-infectives and cardiovascular drugs.
Novartis
NVS
Mkt Cap297.35B
Novartis is a multinational pharmaceutical company that competes across several of the same therapeutic areas as Aspen, including generic medicines through its Sandoz division.
Johnson & Johnson
JNJ
Mkt Cap574.66B
Johnson & Johnson operates in the pharmaceutical sector with a broad range of products that compete with Aspen's portfolio, including in the areas of women's health and general medicines.
Merck
MRK
Mkt Cap300.2B
Merck is a global healthcare company that competes with Aspen, particularly in the areas of infectious diseases and cardiovascular health.
GSK
GSK
Mkt Cap116.3B
GlaxoSmithKline competes with Aspen in the development and marketing of pharmaceuticals and vaccines, including in respiratory diseases and HIV.
Abbvie
ABBV
Mkt Cap367.8B
AbbVie competes with Aspen in the pharmaceutical sector, particularly in the areas of immunology and oncology, areas Aspen is expanding into.
Sanofi
SNY
Mkt Cap113.88B
Sanofi competes with Aspen, offering a broad portfolio of drugs that overlap with Aspen's, including in the areas of cardiovascular diseases and central nervous system disorders.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap36.77B
Teva Pharmaceutical Industries is a leading generic pharmaceutical company that competes with Aspen's manufacturing and distribution of generic medicines.
Astrazeneca
AZN
Mkt Cap316.3B
AstraZeneca competes with Aspen in several therapeutic areas, including respiratory, cardiovascular, and metabolic diseases, areas where Aspen also operates.

About

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Show more...
CEO
Mr. Stephen Bradley Saad
Employees
8580
Country
South Africa
ISIN
ZAE000066692

Listings

0 Comments

Share your thoughts

FAQ

What is Aspen Pharmacare stock price today?
The current price of LDZA.STU is €6.9 EUR — it has increased by +2.99% in the past 24 hours. Watch Aspen Pharmacare stock price performance more closely on the chart.
What is Aspen Pharmacare stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aspen Pharmacare stocks are traded under the ticker LDZA.STU.
Is Aspen Pharmacare stock price growing?
LDZA.STU stock has risen by +2.99% compared to the previous week, the month change is a +1.47% rise, over the last year Aspen Pharmacare has showed a +4.55% increase.
When is the next Aspen Pharmacare earnings date?
Aspen Pharmacare is going to release the next earnings report on September 02, 2026.
What were Aspen Pharmacare earnings last quarter?
LDZA.STU earnings for the last quarter are 0.32 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Aspen Pharmacare have?
As of April 13, 2026, the company has 8,580 employees.
In which sector is Aspen Pharmacare located?
Aspen Pharmacare operates in the Health & Wellness sector.
When did Aspen Pharmacare complete a stock split?
Aspen Pharmacare has not had any recent stock splits.
Where is Aspen Pharmacare headquartered?
Aspen Pharmacare is headquartered in Durban, South Africa.